0.99

12.39% -0.14

Silo Pharma Inc (SILO)

Overview News Price History Financials Discussions Forecast Stock Split

Silo Pharma Inc stock is traded at $0.99, with a volume of 829.19K. It is down -12.39% in the last 24 hours and down -18.18% over the past month. SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Previous Close:

$1.13

Open:

$1.08

24h Volume:

829.19K

Relative Volume:

4.74

Market Cap:

$4.40M

Revenue:

$72,100

Net Income/Loss:

$-3.60M

P/E Ratio:

-0.5893

EPS:

-1.68

Net Cash Flow:

$-3.37M

1W Performance:

-25.00%

1M Performance:

-18.18%

6M Performance:

-50.75%

1Y Performance:

-37.58%

1-Day Range:

$0.98

$1.10

1-Week Range:

$0.98

$1.34

52-Week Range:

$0.841

$4.50

Silo Pharma Inc Stock (SILO) Company Profile

Name

Silo Pharma Inc

Sector

Healthcare (1196)

Industry

Biotechnology (683)

Phone

(718) 400-9031

Address

677 N. WASHINGTON BLVD, SARASOTA

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

SILO's Discussions on Twitter

Compare SILO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SILO	1.56	17.96M	0	0	0	0.00
GOODO	22.16	372.90M	0	0	0	0.00
PSNYW	0.141	297.56M	2.07B	-1.42B	-1.37B	-0.1344
MOBBW	0.16	278.60M	0	0	0	0.00
SHMD	2.61	114.98M	0	0	0	0.00
JUNE	4.95	63.87M	0	0	0	0.00

Silo Pharma Inc Stock (SILO) Latest News

Nov 18, 2024

Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders - The Manila Times

Nov 18, 2024

Silo Pharma reports progress in PTSD treatment study - Investing.com

Nov 18, 2024

Nov 15, 2024

Silo Pharma Third Quarter 2024 Earnings: US$0.22 loss per share (vs US$0.21 loss in 3Q 2023) - Yahoo Finance

Nov 15, 2024

Nov 02, 2024

SILOSilo Pharma, Inc. Latest Stock News & Market Updates - StockTitan

Nov 02, 2024

Oct 31, 2024

Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant - GlobeNewswire

Oct 31, 2024

Silo Pharma, Inc. Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant - Marketscreener.com

Oct 31, 2024

Oct 20, 2024

Exclusive Come Home Trailer Previews Horror Thriller Movie Featuring Silo Stars - ComingSoon.net

Sep 19, 2024

Egypt: General Company for Silos’s profits rise 45.6% YoY in FY2023/24 - ZAWYA

Sep 19, 2024

Sep 18, 2024

Silvis Materials Awarded $1 Million NSF SBIR Phase II Grant to Reduce Emissions in Packaging and Building - EIN News

Sep 18, 2024

FDA Grants Accelerated Approval to Gilead’s Livdelzi for Primary Biliary Cholangitis - The Healthcare Technology Report.

Sep 18, 2024

Sep 17, 2024

Serpin Pharma and Uniklinikum Erlangen Team Up for a Clinical Trial to Prevent Acute Kidney Injury - EIN News

Sep 17, 2024

Sep 16, 2024

New Silo Season 2 Character Is Very Closely Copying An Iconic 2000s TV Show - Screen Rant

Sep 16, 2024

Roli Mosimann (Swans / Wiseblood / The The) has died - Brooklyn Vegan

Sep 16, 2024

Sep 14, 2024

SosMula Finally Delivers "SLEEZ RELIGION" - HotNewHipHop

Sep 14, 2024

Silo season 2: Apple TV Plus release date, likely cast, story rumors, and more news about the sci-fi show's return - TechRadar

Sep 14, 2024

Sep 12, 2024

Silo Pharma completes pre-IND meeting with FDA on SPC-15 for PTSD - BioWorld Online

Sep 12, 2024

Sep 11, 2024

Financial Metrics Exploration: Understanding SILO Pharma Inc (SILO) Through Ratios - The Dwinnex

Sep 11, 2024